- Advertising
- Asia
- Bangladesh
- Biological Inventions
- BRAND VALUATION
- China
- Comparative Advertisement
- Copyright
- Copyright Infringement
- Copyright Litigation
- Counterfeiting
- Covid
- Design
- Digital Marketing Rights
- DRM
- Geographical Indication
- India
- Indian Patents Act
- Indonesia
- Intellectual Property
- Interim Injunction
- IP Commercialization
- IP Licensing
- IP Litigation
- IP Practice in India
- IPAB
- IPAB Decisions
- Japan
- Legal Issues
- Licensing
- Malaysia
- Myanmar
- NCLT
- NEPAL
- Net Neutrality
- News & Updates
- Office
- Patent Commercialisation
- Patent Cooperation Treaty
- patent infringement
- Patent Licensing
- Patent Litigation
- Patent Opposition
- Patent Prosecution
- Patent Rule Amendment
- Patent Term Extension
- Patents
- pharma
- Philippines
- Punitive Damages
- Section 3(D)
- section 64
- Singapore
- South-east Asia
- Technology
- Technology Transfer
- Thailand
- Trademark
- Trademark Litigation
- Uncategorized
- USPTO
- Vietnam
- WIPO
Musical Work Used Commercially And Its Licensing Requirements
You cannot play music for your employees or the public in an office or shop or any commercial spaces, no matter what the medium is (phone system, radio, and disc, TV, or Bluetooth speakers). Business organizations or Entities that are interested in having singers sing or perform in their premises for any purpose need to … Continue reading Musical Work Used Commercially And Its Licensing Requirements
Read more »A Brief Analysis Of Compulsory Licensing Pertinent To Copyright Law
Introduction As the title suggests, this particular blog deals with the compulsory licensing of copyright in our country. However, in order to understand compulsory licensing, the concept pertinent to “licenses” needs to be grasped first. Licenses are of two categories: one being voluntary license and the other being compulsory license. Section 30 of the Copyright … Continue reading A Brief Analysis Of Compulsory Licensing Pertinent To Copyright Law
Read more »Zooming Out On Compulsory Licensing Of Covid-19 Vaccines
The unnerving bio- catastrophe, the COVID-19 pandemic has brought an array of challenges for mankind. The COVID-19 scare at the global level is posing threat to human life and the governments are deeply divided over an effort to endorse a temporary patent waiver on COVID-19 vaccines and grant of compulsory licenses. What is Compulsory Licensing? … Continue reading Zooming Out On Compulsory Licensing Of Covid-19 Vaccines
Read more »Sisvel and Mitsubishi, and Xiaomi sign patent licensing deal to settle ongoing litigations
Recently, Sisvel and Mitsubishi jointly announced that the companies have entered into a patent license agreement covering the standard-essential patents (SEP) of Mitsubishi Electric and Sisvel in the field of mobile communication. This deal brings to an end the global dispute between the three companies, which has spanned the courts in China, Germany, Italy, the … Continue reading Sisvel and Mitsubishi, and Xiaomi sign patent licensing deal to settle ongoing litigations
Read more »DelSiTech and Visus Therapeutics enter into Patent Licensing Arrangement
Recently, DelSiTech Ltd. (“DelSiTech”), a Finland-based drug delivery company entered into a patent licensing agreement over DelSiTech’s patents with Visus Therapeutics (“Visius”), a US-based company. This is a worldwide exclusive licensing agreement. Both companies are working on six development programs for eye care solutions targeting the management of ocular diseases of the back and front … Continue reading DelSiTech and Visus Therapeutics enter into Patent Licensing Arrangement
Read more »ERS Genomics Licenses CRISPR-Cas9 patent and technology to Cellular Engineering Technologies
Recently, Dublin, Ireland-based biotechnology company, ERS Genomics Limited (“ERS”), has signed a nonexclusive license agreement with Iowa-based Cellular Engineering Technologies (“CET”) to grant access to its CRISPR-Cas9 patent portfolio. The financial terms of the agreement were not disclosed. ERS was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property for use as a … Continue reading ERS Genomics Licenses CRISPR-Cas9 patent and technology to Cellular Engineering Technologies
Read more »Sun Pharma and Celegene Settle Patent Dispute over Lenalidomide (Revlimid®)
Settling an over three old patent infringement dispute, Indian pharmaceutical major, Sun Pharmaceuticals and its subsidiary, including US subsidiary (“Sun”), has reached a settlement with Celgene Corporation (“Celgene”), a subsidiary of pharmaceutical major Bristol Myers Squibb (BMS), to resolve and settle the patent litigation regarding submission of an Abbreviated New Drug Application (ANDA) for a … Continue reading Sun Pharma and Celegene Settle Patent Dispute over Lenalidomide (Revlimid®)
Read more »Bajaj Healthcare Files Compulsory License with Indian Patent Office for Baricitinib
Recently, drug manufacturer, Bajaj Healthcare Limited issued a press release stating that they have filed a compulsory license application with the Indian Patent Office seeking permission to manufacture both active pharmaceutical ingredients (raw materials) and formulation of Baricitinib under the Indian Patents Act. Baricitinib is essentially a drug approved in the US and European Union, … Continue reading Bajaj Healthcare Files Compulsory License with Indian Patent Office for Baricitinib
Read more »Elli Lilly Enters into Licensing Deals with Indian Companies
Recently, Elli Lilly, a US-based major Pharmaceutical company, has entered into licensing agreements with a number of Indian drug manufacturers for the manufacture of and supply of Baricitinib in India which is showing promise as a drug for the treatment of Covid-19. The licensing agreement with Eli Lilly is voluntary, royalty-free, and non-exclusive in nature … Continue reading Elli Lilly Enters into Licensing Deals with Indian Companies
Read more »Merck Enters into Licensing Deal with Five Indian Companies for Supply of Oral Covid-19 Drug
Recently, Merck, also known as MSD, has entered into licensing agreements with five Indian generics drug manufacturers to manufacture and supply oral Covid-19 drug Molnupiravir. MSD India is a wholly-owned subsidiary of Merck Sharp & Dohme (MSD) and is known as Merck & Co., Inc, in the United States and Canada. Under the agreements, Merck … Continue reading Merck Enters into Licensing Deal with Five Indian Companies for Supply of Oral Covid-19 Drug
Read more »